Lexicon earns $10M milestone from Novo Nordisk for obesity drug
Press release from Novo Nordisk regarding $10M milestone achievement for Wegovy obesity treatment
Had it been observed at this time, the $2.02 price level was above the $1.96 support line, making it worth considering for a buy, while the $2.52 resistance level was a zone for confirming a potential rebound. The confirmation of 1.10x trading volume alongside news catalysts was also a positive factor.
If the price breaks above $2.52 resistance, take profits; if $1.96 support breaks below, cut losses.
RSI(14) 48.6, 20-day moving average golden cross, trading volume 1.10 times the 20-day average, 7-day change rate -2.1%
There are no direct comparable cases based on the provided information, making direct comparison with other stocks difficult, though it can be referenced as a general pattern within the theme.
Predicted return +4.5% versus actual result -12.2%, stop-loss line $1.96 downward breach, goal not achieved. RSI 48.6 and 1.10x trading volume indicators differed from the expected flow. The primary cause was market chill and heightened volatility.
In the next trade, set RSI and volume thresholds more conservatively, and enter a position after confirming initial volatility following positive news announcement. Reduce position size near stop-loss levels to limit risk.